Sjögren's syndrome: an oligo-monoclonal B cell process

Area of Science:

• Immunology
• Rheumatology
• Oncology

Background:

• Primary Sjögren's syndrome (1° SS) is recognized as a significant model for investigating autoimmunity.
• It is also a crucial area for studying B-cell neoplasia, with accumulating evidence supporting this role.

Purpose of the Study:

• To explore the common pathogenetic links between benign and malignant lymphoproliferation in Primary Sjögren's syndrome.
• To consolidate evidence supporting 1° SS as a model for autoimmunity and B-cell neoplasia.

Main Methods:

• Analysis of non-Hodgkin's lymphoma (NHL) incidence in 1° SS patients.
• Detection of circulating monoclonal immunoglobulins and uniform immunoglobulin gene rearrangements.
• Assessment of monoclonal B-cell expansions in salivary gland infiltrates.
• Evaluation of increased circulating CD5 positive B-cells and their association with monoclonal immunoglobulins.
• Identification of shared cross-reactive idiotypes on monoclonal immunoglobulins in 1° SS and B-cell malignancies.

Main Results:

• 1° SS patients exhibit a higher incidence of non-Hodgkin's lymphoma (NHL).
• Monoclonal immunoglobulins and uniform immunoglobulin gene rearrangements are present in these patients.
• Salivary gland infiltrates show monoclonal B-cell expansions.
• Elevated levels of circulating CD5 positive B-cells are associated with monoclonal immunoglobulins.
• Shared idiotypes link 1° SS immunoglobulins to B-cell malignancies.

Conclusions:

• Evidence strongly supports common pathogenetic links between benign and malignant lymphoproliferation in 1° SS.
• 1° SS serves as a valuable model for understanding the development of both autoimmune disorders and B-cell cancers.
• The findings highlight the intricate relationship between autoimmune processes and lymphomagenesis in 1° SS.